Brexit is a significant subject for R&I lawyers due to the reciprocal nature of our relationship with Europe. Our Brexit content offers key information and updates for all practitioners, as well as legislation trackers.
Includes new legislation due to coronavirus. Temporary provisions centre around winding-up petitions, wrongful trading and ipso facto clauses. Permanent changes include the creation of two corporate insolvency processes.
Get country guides for 45 jurisdictions – the majority are from our Getting the Deal Through series. Where there are jurisdictional gaps, we have commissioned content, and have created several comparison tables.
Helping restructuring and insolvency professionals stay up-to-date with legal and market developments, and work faster and smarter.
This week’s edition of Restructuring & Insolvency weekly highlights includes a look at the Queen’s Speech and the implications for R&I professionals,...
Law360, London: The reputation for quality at City law firms reassures the rest of the world that it can invest and litigate in England's courts—but...
Restructuring & Insolvency analysis: This article looks at how Germany has implemented Directive (EU) 2019/1023 as part of the Joint Project between...
Restructuring & Insolvency analysis: The High Court has held that it was necessary to imply into a brand licence agreement, a term which required the...
Restructuring & Insolvency analysis: This article looks at how Cyprus has implemented Directive (EU) 2019/1023 as part of the Joint Project between...
INSOL Europe/Lexis®PSL Joint Project on EU Harmonisation Directive 2019/1023: consolidated tableLexis®PSL are working with INSOL Europe on a joint...
Australia—arrangements and reconstructionsScope of provisionsAlthough the provisions of the Corporations Act (CA 2001) relating to arrangements and...
Coronavirus (COVID-19)—implications for property [Archived]This archived Practice Note introduced the key implications that property practitioners...
Remote and hybrid hearings in civil proceedingsThis Practice Note gives guidance on remote and hybrid hearings, via video-conference and telephone, in...
What constitutes unfitness under section 6 of the Company Directors Disqualification Act 1986?STOP PRESS: In May 2021 the government announced that...
Hardship clauseHardship•means[, subject to clause [1.6 OR 1.7],] a [fundamental OR material] change in the balance of a party’s benefits and...
COVID-19 Standard Conditions for Company Voluntary ArrangementsPart 1: Interpretation1Miscellaneous definitions1.1In the Arrangement, except where the...
Appendix 2: Amendments to R3 Standard Form COVID-19 CVA proposal (Scotland) for exit from administrationFront page: replace heading with: ‘IN THE...
Demand letter—borrower[To be printed on headed notepaper of the lender making demand]To: [Insert name of individual and/or position][insert name of...
Special administration—company board minutes[INSERT NAME OF INVESTMENT BANK]Minutes of a meeting of the board of directors of [insert name of...
RecapitalisationsThe term 'recapitalisation' refers to a company changing the proportions of its debt and equity, something which can be achieved in a...
The Loan Market AssociationAims of the Loan Market AssociationThe Loan Market Association (LMA) was established in 1996 as a trade body with a key...
Understanding official copy entries from an enforcement point of viewThis Practice Note considers the review of official copy entries (commonly called...
Receivership—an introductory guideThe appointment of a receiver is a remedy for creditors and certain third parties to protect their interest in...
Future debts, contingent debts, secured debts—the position under the Insolvency (England and Wales) Rules 2016Provable debtsThe general rule as to...
Scotland: the process for applying for sequestrationFor the impact of Brexit on Scottish procedures, see Practice Note: Table showing impact of Brexit...
Comity and the court's inherent jurisdiction—application and effectsComityComity is the general common law principle that courts will recognise and...
What effect does an insolvency process have on ongoing litigation and arbitration proceedings?This Practice Note discusses:•the effect of an...
Key provisions of the financial collateral regulationsRationaleThe Financial Collateral Directive was first implemented in the UK under the Financial...
The Temporary Insolvency Practice Direction Supporting the Insolvency Practice Direction (June 2021) [Archived]Background to the Temporary Insolvency...
Court-appointed receivers—when a court will appoint a receiver and who may be appointedThis Practice Note covers receivers who are appointed by the...
Rejection of proof of debt—the position under the Insolvency (England and Wales) Rules 2016Insolvency (England and Wales) Rules 2016The rules...
Security Review—example structure chartA structure chart showing the corporate structure of a borrower together with the security granted in favour of...
Claim form (CPR Part 8) in respect of an application for a scheme of arrangement[IN THE HIGH COURT OF JUSTICE BUSINESS AND PROPERTY COURTS [OF ENGLAND...
Secured creditors under a CVA—including effect on guaranteesNeither the company nor its creditors may approve a company voluntary arrangement (CVA)...
Witness statement in support of application for substituted service of a bankruptcy petitionApplicant: [insert initials and surname]: 1st:...
Arbitration that arises out of commercial transactions (eg an international contract for the sale of goods or a construction project), usually between private parties, but sometimes involving states or state-owned entities. Commercial arbitration may be contrasted with investment treaty arbitration and sports arbitration.
Intellectual property rights need to fulfil certain requirements to be deemed valid. The requirements are generally based on intrinsic qualities of the right (eg a trade mark must not be descriptive) and on conflicts with earlier rights (eg an invention must be novel in order to be patented).
A supplementary protection certificate (SPC) extends the protection conferred by a patent to a particular plant protection or medicinal product by up to five years, provided certain conditions are met.